Acute Bronchiolitis
The only salt inhaler with controlled emission of aerosols for the treatment of respiratory diseases.
Acute Bronchiolitisis an acute inflammatory injury of the bronchioles, the smallest air passages of the lungs. It usually occurs in children less than two years of age with the majority being aged between three and six months. This inflammation is usually caused by respiratory syncitial virus (70% of cases) and is much more common in the winter months.
In a typical case an infant may develop a cough, wheeze and shortness of breath over one or two days. Some signs of severe disease, requiring medical consultation, include increased respiratory rate and presence of nasal flaring and/or grunting.
After the acute illness it is common for the airways to remain sensitive for several weeks, leading to a recurrent cough and wheezing.
In addition to the treatment recommended by the medical practitioner, the SaltMed saline inhaler may ensure the following through its controlled emission of dry, saline particles:

- Immediate improvement of the cough and ease of respiration due to a reduction of inflammation at a lower airway level
- Increased elimination of bronchial secretions (more productive cough) due to an increase in the fluidisation of the tracheobronchial secretions.
- More rapid healing, the prevention of recurrent acute bronchiolitis episodes and an improvement in local defense mechanisms due to SaltMed's antibacterial effect.

SaltMed is a safe and efficient therapy and easy to use, even for very small children.
Contact us
Tel. /fax: (+4) 021 334 93 57
Mobile: (+4) 0723 20 30 85